Biopharma company Alnylam Pharmaceuticals (NASDAQ:ALNY) has built a brand on its innovative RNAi therapeutics. ALNY’s focus: developing a pipeline of drugs designed to help transform lives of patients with rare
Biopharma company Alnylam Pharmaceuticals (NASDAQ:ALNY) has built a brand on its innovative RNAi therapeutics. ALNY’s focus: developing a pipeline of drugs designed to help transform lives of patients with rare
Smart speaker maker Sonos Inc (NASDAQ:SONO) has a slew of Wall Street analysts tuning in- especially after the tech stock’s NASDAQ debut on August 2. Shares of SONO kicked off
Clinical-stage biopharma Immunomedics (NASDAQ:IMMU) is a heavyweight player soaring in the worldwide antibody-drug conjugate (ADC) market. In other words, IMMU specializes in cancer therapies; and it’s been a standout year
Tinder parent company Match Group Inc (NASDAQ:MTCH) scored a home run on its second quarter earnings show- and has stirred up clear Street-wide intrigue ever since. Just how good was
Chinese e-commerce king Alibaba (NYSE:BABA) had a slam dunk year in 2017- the stock raced almost 95%. Present-day, shares are trading over $172 and the company has hooked a $444.3